Results 101 to 110 of about 148,412 (201)

Infectious mononucleosis, other infections and prostate-specific antigen concentration as a marker of prostate involvement during infection [PDF]

, 2016
Aksoy, Alanen, Ascherio, Ayatollahi, Banez, Basch, Bergh, Berrington de Gonzalez, Borgermann, Bosch, Carter, Catalona, Chen, Elgamal, Fan, Fedewa, Grinstein, Hasui, Heidenreich, Joshi, Kadayifci, Kadayifci, Kilic, Krystyna, Kuller, Kutok, Lilja, Luzuriaga, Malavaud, Mandel, Moyer, Olsson, Oremek, Rickinson, Rubertone, Sfanos, Silverberg, Sindhwani, Smith, Stamey, Sutcliffe, Sutcliffe, Sutcliffe, Tchetgen, Whitaker, Whittemore, Wolf   +46 more
core   +2 more sources

Free/total PSA ratio

, 2017
Yuranga Weerakkody, Henry Knipe, Daniel Bell   +2 more
openaire   +1 more source

The clinical usefulness of percent free-PSA

Urology, 1996
A W, Partin, J E, Oesterling
openaire   +2 more sources

Roche Diagnostics Free PSA Test [PDF]

, 2020
openaire   +1 more source

Comparison of percentage free PSA, MRI and GaPSMA PET scan for diagnosing cancer prostate in men with PSA between 4 and 20 ng/ml.

Indian J Urol, 2019
Kumar N, Yadav S, Kumar S, Saurav K, Prasad V, Vasudeva P.   +5 more
europepmc   +1 more source

Editorial Comment on Beyond Total PSA: Clinical Significance of S2,3PSA% in Reducing Unnecessary Prostate Biopsies. [PDF]

Int J Urol
Goto Y.
europepmc   +1 more source

PSMA PET-guided intensification of postprostatectomy salvage radiotherapy for prostate cancer: a systematic review and meta-analysis. [PDF]

Front Oncol
Liu G, Shu Y, Hong J, Li Z, Yang X.
europepmc   +1 more source

Integrating Tumor Biology and Host Factors in mCRPC: The Prognostic Value of 'Time to Castration Resistance', Systemic Inflammation, and Comorbidity Burden in Patients Treated with Enzalutamide. [PDF]

Diagnostics (Basel)
Sali S, Ulaş A, Oyucu Orhan S, Topçu S, Koçar M, Sali M, Ocak B, Deligönül A, Evrensel T, Çubukçu E.   +9 more
europepmc   +1 more source

An Approach Using PSA Levels of 1.5 ng/mL as the Cutoff for Prostate Cancer Screening in Primary Care. [PDF]

, 2016
Arangua, Paul, Carroll, Peter, Cooperberg, Matthew R., Crawford, E. David, Eastham, James, Gomella, Leonard G., Hoenemeyer, John, Klein, Eric A., Leapman, Michael, Leveridge, Mike, Loeb, Stacy, Maccini, Michael, Partin, Alan W., Pettaway, Curtis A., Pinto, Peter, Rosenberg, Matt T., Shore, Neal D., Thompson, Ian M.   +17 more
core   +2 more sources

Oncological outcomes post focal low-dose-rate brachytherapy in low-intermediate risk prostate cancer. [PDF]

BJUI Compass
Adhami M, Cheng J, Anderson E, Smyth L, Davey C, Nguyen T, O'Sullivan R, Ryan A, Lawrentschuk N, Grummet J, See A.   +10 more
europepmc   +1 more source